Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-05-13 2020-05-13
Drug Identification Number 02443937 02443937
Brand name JARDIANCE JARDIANCE
Common or Proper name Jardiance 90s Jardiance 90s
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients EMPAGLIFLOZIN EMPAGLIFLOZIN
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90s 90s
ATC code A10BK A10BK
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-05-29 2020-05-29
Actual start date
Estimated end date 2020-06-08 2020-06-08
Actual end date 2020-05-13 2020-05-13
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments
Health Canada comments